📰 Tim Van Biesen News
Tim Van Biesen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tim Van Biesen. Real-time updates on events, politics, business and more.
December 2, 2022
World-first peanut allergy drug Palforzia’s poor sales spark concerns over future drug research.
August 8, 2022
/PRNewswire/ -- Bain & Company, a top global management consultancy, and Trinity Life Sciences, a leader in global life sciences commercialization solutions,...
January 20, 2022
/PRNewswire/ -- Hero, the market leader for digital in-home care, focused today on medication management, has created an Advisory Board comprising recognized...
January 20, 2022
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- Hero, the market leader for digital in-home care, focused today on medication management, has created an A...
January 20, 2022
/PRNewswire/ -- Hero, the market leader for digital in-home care, focused today on medication management, has created an Advisory Board comprising recognized...
April 8, 2021
“T HE IMPOSSIBLE can many times become possible,” reflects Albert Bourla, boss of Pfizer. He is talking about the giant American drugmaker’s speedy development (with BioNTech of Germany) of a vaccine against covid-19. The sentiment also applies to the turnaround in the fortunes of the pharmaceutical industry. Listen to this story Enjoy more audio and podcasts oniOSorAndroid. Before the pandemic Big Pharma was in big trouble. It was widely criticised for investing more in marketing than in...